Cargando…
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
OBJECTIVE: Persistent infection of HPV increases the chance of carcinoma in situ of cervix through stages of cervical intraepithelial neoplasia (CIN) 1, 2, and 3, and finally progresses into cervical cancer. We aimed to explore the safety and efficacy of BLS-M07 which is orally administered agent ex...
Autores principales: | Park, Young-Chul, Ouh, Yung-Taek, Sung, Moon-Hee, Park, Hong-Gyu, Kim, Tae-Jin, Cho, Chi-Heum, Park, Jong Sup, Lee, Jae-Kwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779607/ https://www.ncbi.nlm.nih.gov/pubmed/31576684 http://dx.doi.org/10.3802/jgo.2019.30.e88 |
Ejemplares similares
-
Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization
por: Chang, Hyeyoon, et al.
Publicado: (2018) -
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
por: Zhang, Ning, et al.
Publicado: (2020) -
Clinical Outcomes Associated with Endocervical Glandular Involvement in Patients with Cervical Intraepithelial Neoplasia III
por: Kim, Nae Ry, et al.
Publicado: (2022) -
Short-term clinical and immunologic effects of poly-gamma-glutamic acid (γ-PGA) in women with cervical intraepithelial neoplasia 1 (CIN 1): A multicenter, randomized, double blind, phase II trial
por: Cho, Hyun-Woong, et al.
Publicado: (2019) -
High-Dose-Rate Brachytherapy for the Treatment of Vaginal Intraepithelial Neoplasia
por: Song, Jin Ho, et al.
Publicado: (2014)